相关实验视频

Updated: Jun 30, 2025

Author Spotlight: Multiplex Immunofluorescence Combined with Spatial Image Analysis for the Clinical and Biological Assessment of the Tumor Microenvironment

Author Spotlight: Multiplex Immunofluorescence Combined with Spatial Image Analysis for the Clinical and Biological Assessment of the Tumor Microenvironment

Published on: June 2, 2023

高多元单细胞成像分析揭示了与CAR T细胞治疗后临床结果相关的瘤免疫背景

Jin Jin¹, Li Lin², Jiao Meng³

¹Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China; Immunotherapy Research Center for Hematologic Diseases of Hubei Province, Wuhan 430030, China; Department of Hematology, Renmin Hospital of Wuhan University, Wuhan 430060, China.

Molecular therapy : the journal of the American Society of Gene Therapy

|March 20, 2024

概括

化学抗原受体 (CAR) T细胞疗法显示了可变的淋巴瘤治疗成功率. 这项研究揭示了瘤微环境,包括免疫细胞类型及其空间布局,如何影响扩散大B细胞淋巴瘤中CAR T细胞治疗结果.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
生物医学工程生物医学工程

背景情况:

化学抗原受体 (CAR) T细胞疗法对淋巴瘤治疗具有前景,但患者的结果有很大差异.
瘤微环境越来越被认为是影响CAR T细胞治疗疗效的关键因素.

研究的目的:

研究扩散性大B细胞淋巴瘤 (DLBCL) 微环境与CAR T细胞治疗结果之间的关系.
确定与治疗反应和缓解持续时间相关的特定细胞和空间特征.

主要方法:

利用高度多重成像质细胞计 (IMC) 面板量化了13名DLBCL患者20个组织段中的31个生物标志物.
在CAR T细胞输注前后,分析瘤微环境中的细胞组成,状态和空间安排.
识别并重新定义了35个细胞成10个元,以便进行全面的分析.

主要成果:

更高的CD4+T细胞分数与更长的缓解持续时间正相关.
糟糕的结果与T细胞Ki67,CD57,TIM3的表达增加和CD69的减少有关,特别是在CD8+/CD4+效应记忆 (Tem) 和效应 (Te) T细胞子集中.
富含免疫细胞的邻里预测了更长的缓解期,而纤维细胞和血管内皮细胞与瘤细胞的接近表明反应不佳.

结论:

该研究系统地剖析了DLBCL微环境的细胞组成,状态和空间组织,与CAR T细胞治疗结果相关.
通过分析瘤微环境,研究结果为预测CAR T细胞治疗疗效提供了洞察力.
这项研究有助于了解导致患者对CAR T细胞治疗淋巴瘤的可变反应的因素.

关键词:

在CAR T细胞疗法中.扩散大的B细胞淋巴瘤.图像成像质量细胞计量.结果预测结果预测.瘤微环境是一个微环境.

更多相关视频

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.